Stocktoria
CSPC Pharmaceutical Group Limited 1093.HK
CSPC Pharmaceutical Group Limited statistics & valuation
Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
CSPC Pharmaceutical Group Limited trades at about 20.5× earnings — above its 10-year norm (10-year range 11.6×–28.3×, median 17.5×).
Shaded band = 10-year range (11.6×–28.3×); dot = today's 20.5×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 65.6% | 70.0% | 70.5% | 71.9% |
| Operating margin | 16.1% | 18.9% | 22.3% | 21.8% |
| Net margin | 14.9% | 14.9% | 18.7% | 19.7% |
| FCF margin | 13.7% | 6.4% | 7.3% | 15.9% |
| Return on assets | 8.3% | 9.8% | 12.7% | 14.6% |
| Return on equity | 11.7% | 13.4% | 17.7% | 20.2% |
| Debt / equity | — | — | 0.00× | 0.00× |
| Current ratio | 2.19 | 2.27 | 2.63 | 2.67 |
Computed from company filings · HK · as of 2025-12-31. Figures in CNY. Facts plus Stocktoria's own computed scores — not investment advice.